Chief Executive Officer · Pacira BioSciences, Inc. (PCRX)

David Stack

A named executive officer of Pacira BioSciences in every fiscal year CompBrief holds from FY2016 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$6,878,091

Salary $941,387Stock awards $1,266,798Bonus $720,600

FY2022: $6,851,340

1st of 3 named executive officers at Pacira BioSciences by FY2023 total.

3 named officers on file for Pacira BioSciences, FY2023

David Stack’s pay file — $29

  • 8 fiscal years of pay, line by line
  • 10 equity grants, each cited to its filing
  • PCRX’s disclosed peer group of 17 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Pacira BioSciences’s whole pay program stands against its peers

  • Pacira BioSciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on PCRX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 22, 2024 (DEF 14A).

Free

Get David Stack’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

David Stack compensation by year

Pacira BioSciences Summary Compensation Table · all 8 fiscal years held
In US dollars, as Pacira BioSciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023
Salary$761,346$784,187$807,695$831,966$889,935$883,600$910,108$941,387
Bonus$396,344$467,114$679,200$624,675$686,300$751,100$618,900$720,600
Stock awards$1,336,263$1,790,100$1,088,181$1,088,181$1,586,745$1,085,088$1,276,885$1,266,798
Option awards$2,316,516$1,666,848$3,244,433$3,244,433$6,166,589$3,701,206$4,030,545$3,909,786
Non-equity incentive$0$0$0$0$0$506,777$0$0
Pension and deferred compensation$0$0$0$0$0$0$0$0
All other$8,206$10,668$16,409$17,173$14,713$14,713$14,902$39,520
Total$4,818,675$4,718,917$5,835,918$5,806,428$9,344,282$6,942,484$6,851,340$6,878,091

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Pacira BioSciences, Inc. DEF 14A filed April 22, 2024, accession 0001104659-24-049997, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Pacira BioSciences, Inc. filed document, accession 0001104659-24-049997. Every figure is read from that document and cited to the page and table it appears in. Filed April 22, 2024.

$4.8M
$4.7M
$5.8M
$5.8M
$9.3M
$6.9M
$6.9M
$6.9M
FY16
FY17
FY18
FY19
FY20
FY21
FY22
FY23
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
RSU21,500$830,115—
RSU16,650$642,857—
RSU133,500$515,444—
RSU13,350$515,444—
RSU5,925$228,764—
Option103,122—$47.65
Option83,373—$60.96
Option160,900—$59.39
Option17,762—$43.54

Per the Outstanding Equity Awards at Fiscal Year-End table in Pacira BioSciences, Inc.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.

Pacira BioSciences’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
David Stack · this pageChief Executive Officer$6,878,091
Kristen WilliamsChief Administrative Officer and Secretary$1,600,861
Jonathan SloninChief Medical Officer$1,593,213

The full Pacira BioSciences compensation record

free company brief

This page is one person within Pacira BioSciences's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Pacira BioSciences proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Pacira BioSciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

David Stack's compensation dossier · One-time report. No refunds.